Other languages Dechra Pharmaceuticals

Equities

Delayed London S.E. Other stock markets 02:30:00 2024-01-16 am EST			5-day change	1st Jan Change
3,866 ^GBX	-.--%		-.--%	+0.21%

Apr. 11	Dechra Pharmaceuticals Limited reached agreement in principle to acquire 33.34% stake in STEM Animal Health Inc. for $4.7 million.	CI
Apr. 09	Dechra Group Holdings Limited Appoints Paul Nicholas Sandland as Director	CI

Dechra Group Holdings Limited Appoints Paul Nicholas Sandland as Director	Apr. 09
Dechra Group Holdings Limited Appoints Ian David Page as Director	Apr. 09
Dechra Group Holdings Limited Announces Resignation of Thomas Spicer as Director	Apr. 09
Dechra Group Holdings Limited Announces Resignation of Anthony Santospirito as Director	Apr. 09
Dechra Group Holdings Limited Announces Resignation of Sara Huda as Director	Apr. 09
Stocks slump as Fed rate cut hope dwindles	Jan. 17
Dechra Pharmaceuticals Delists From London Bourse Following Freya Bidco’s Takeover	Jan. 17
EQT's Freya Bidco Completes Dechra Pharmaceuticals Purchase	Jan. 16
EQT X EUR SCSp and EQT X USD SCSp managed by Eqt Fund Management S.à R.L. and Luxinva SA (the Offerors) completed the acquisition of Dechra Pharmaceuticals PLC.	Jan. 15
BOLETÍN MATINAL : 12 de enero de 2024	Jan. 12
Persimmon to replace outbound FTSE 100 constituent Dechra	Jan. 12
EU clears Dechra Pharmaceuticals takeover by EQT funds	Dec. 27
EQT's Dechra Takeover to Become Effective in Mid-January 2024	Dec. 27
EQT's Takeover of Dechra Pharmaceuticals Gets EU Antitrust Regulator's Nod	Dec. 22
Inchcape to appoint Jerry Buhlmann to chair board of directors from May	Dec. 14
Pharma und Gesundheit: weitere Konsolidierung	Dec. 13
Farma en gezondheid: consolidatie gaat door	Dec. 12
Farmaceutica e salute: continua il consolidamento	Dec. 11
Farmacia y salud: La consolidación continúa	Dec. 11
Pharma & santé : poursuite de la consolidation	Dec. 11

No results for this search